Seacoast Banking Corporation of Florida filings document the regulatory record of a Florida bank holding company whose principal operating subsidiary is Seacoast National Bank. Its 8-K reports furnish quarterly and annual results, investor presentations, Regulation FD materials, securities-portfolio actions and other material events tied to bank earnings, deposits, net interest income, capital and liquidity.
Proxy and governance filings describe annual meeting matters, board composition, director elections, compensation and shareholder voting items. Transaction and capital-structure disclosures document completed bank acquisitions, amendments related to Series A Non-Voting Preferred Stock, rights of security holders and other matters affecting Seacoast's common and preferred equity.
HUDSON DENNIS S III reported acquisition or exercise transactions in this Form 4 filing.
Seacoast Banking Corp of Florida director Dennis S. Hudson III received a grant of 2,015 shares of common stock on July 31, 2026 at a reported value of $34.74 per share, issued from the 2021 Incentive Plan for 2026 board service and held in a trust. He also holds rights to buy 55,279 shares at $31.15 expiring April 2, 2028 and 78,021 shares at $28.69 expiring April 3, 2027 under the Amended and Restated 2013 Incentive Plan, plus additional direct and indirect common stock holdings through family-related accounts and entities.
SHEAROUSE JOSEPH B III reported acquisition or exercise transactions in this Form 4 filing.
Seacoast Banking Corp of Florida director Joseph B. Shearouse III received a grant of 2,015 shares of common stock on July 31, 2026 at $34.74 per share, issued from Seacoast's 2021 Incentive Plan for Board Services in 2026. He also reports 40 shares held indirectly through his spouse and additional direct holdings in an IRA.
HUDSON DALE M reported acquisition or exercise transactions in this Form 4 filing.
Dale M Hudson, a subsidiary director of Seacoast Banking Corp of Florida, received an award of 2,015 shares of common stock on July 31, 2026 at $34.74 per share. The restricted stock was issued under Seacoast's 2021 Incentive Plan and deferred into the Non-employee Directors Deferred Compensation Plan. Additional holdings include share equivalents in the Retirement Savings Plan, jointly held shares with his spouse, interests through a family partnership, and 7,191 shares held indirectly through his spouse.
Seacoast Banking Corporation of Florida director Dennis J. Arczynski received a grant of 2,015 shares of Common Stock on July 31, 2026, at $34.74 per share. The shares were issued for 2026 Board services under Seacoast's 2021 Incentive Plan and are held in an LLC he controls with sole voting and dispositive power.
He also directly holds a stock option described as a Common Stock Right to Buy covering 2,142 underlying Common shares at an exercise price of $22.65, expiring February 6, 2027, granted under the 2013 Incentive Plan, along with other Common Stock positions through a non-employee directors deferred compensation plan, joint ownership with his spouse, and a SEP Plan.
Seacoast Banking Corporation of Florida director Jacqueline Lynette Bradley received an award of 2,015 shares of restricted common stock on 2026-07-31 at a reference value of $34.74 per share. The award was issued under the 2021 Incentive Plan for 2026 director service and deferred into her account in the company’s Directors Deferred Compensation Plan and Non-employee Directors Deferred Compensation Plan. She also holds “Common Stock Right to Buy” awards under the 2013 and 2021 Incentive Plans covering 1,505, 2,142, 1,431 and 1,146 underlying shares at exercise prices between $22.65 and $35.78, expiring from 2027 through 2032.
GRIFFIN MICHAEL E reported acquisition or exercise transactions in this Form 4 filing.
Seacoast Banking Corp of Florida director Michael E. Griffin received a grant of 2,015 shares of Common Stock on 2026-07-31 at $34.74 per share. The stock was issued under Seacoast's 2021 Incentive Plan for Board Services in 2026, increasing his direct holdings to 2,115 shares.
SEACOAST BANKING CORP OF FLORIDA reports that subsidiary director H. Gilbert Culbreth Jr. was granted 2,015 shares of common stock on 2026-07-31 at 34.7400 per share as restricted stock for 2026 board service, deferred into the company’s directors deferred compensation plan. He also holds a right to buy 2,142 common shares at an exercise price of 22.6500 until 2027-02-06, plus various direct and indirect holdings including 26,000 shares in a family limited liability company and 8,200 shares in a family sub-S corporation.
Lipstein Robert J reported acquisition or exercise transactions in this Form 4 filing.
Seacoast Banking Corp of Florida director Robert J. Lipstein received a grant of 2,015 shares of common stock on July 31, 2026, valued at $34.74 per share, as stock issued from Seacoast's 2021 Incentive Plan for Board services in 2026. Footnotes indicate certain reported holdings are held jointly with his spouse and in an IRA.
Seacoast Banking Corp of Florida Chairman, President & CEO Charles M. Shaffer exercised stock rights for 28,544 shares of common stock at an exercise price of $28.69 per share on 2026-08-04. To fund the exercise and related tax withholding, he sold 25,851 shares at a weighted average price of $35.47 per share. He also continues to hold options on 18,952 shares at $31.15 per share, expiring in 2028, plus various unvested restricted stock and plan-based share holdings.
Seacoast Banking Corporation of Florida reported net income of $59.5 million for the quarter ended June 30, 2026, up from $42.7 million a year earlier. Net interest income rose to $180.4 million as interest income growth outpaced higher funding costs, while diluted EPS was $0.55 versus $0.50.
Total assets reached $21.36 billion at June 30, 2026, with loans of $13.15 billion and deposits of $16.79 billion, including balances added from the 2025 Villages Bancorporation and Heartland acquisitions. Credit quality remained manageable: nonaccrual loans were $86.5 million and the allowance for credit losses was $182.1 million, or 1.38% of loans held for investment.
Results were affected by securities repositioning; during the first half of 2026 the company realized net securities losses of $39.6 million on $277.2 million of available-for-sale sales, which significantly reduced noninterest income. Regulatory capital ratios at both the holding company and Seacoast Bank exceeded well-capitalized requirements under the Basel III framework.